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A 52 year old lady presented with non-speciﬁc abdominal symptoms and menorrhagia. Ultrasound scan
revealed an incidental ﬁnding of a large soft tissue mass. This was further characterised with a CT scan
which revealed a 15 cm  10 cm  7 cmmultilobulated mass. This was removed via a subtotal colectomy.
Initial histology was reported as a most likely diagnosis of gastro-intestinal stromal tumour (GIST) but
further characterisation revealed this to be a low-grade ﬁbromyxoid sarcoma.
This is only the second reported case of low-grade ﬁbromyxoid sarcoma of the colon and would
potentially have been missed had not the sample been sent for second opinion at a regional specialist
centre.
Copyright © 2014 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Pathologists.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).1. Case history
A 52 year old lady was referred to gynaecology outpatients with a 2 year history of menorrhagia and intermenstrual bleeding. She also
described occasional mild abdominal distension, a sensation of bloating and feeling nauseated. There was no recent change in her weight,
appetite or bowel habit. She reported occasional ‘hot ﬂushes’ which she had put down to the beginnings of menopause.
She had a past history of hypertension and anxiety and a family history of her father suffering from gastric carcinoma. In view of her
menorrhagia, the gynaecologists arranged an ultrasound scan which revealed 4 soft tissue masses in the right adnexa extending above the
umbilicus measuring 10 cm, 6 cm, 3.7 cm and 3.5 cm. They were separate to the ovaries and the uterus appeared normal. The tissue masses
were reported to contain small blood vessels and a large vessel connecting them. A CT scan, with contrast, revealed a 15 cm 10 cm 7.5 cm
multilobulated soft tissue mass in the central lower abdomen and pelvis, abutting and displacing the transverse colon and stomach, which
was felt to be separate to both the ovaries and uterus (Fig. 1).
The colorectal MDT decisionwas for a laparotomy and resection, with a likely diagnosis of gastrointestinal stromal tumour (GIST) of small
bowel origin. Laparotomy revealed a large cystic tumour in the mid transverse colon emanating from the bowel wall and mesentery. An
additional small deposit was found in the distal sigmoid colon and posterior uterine wall.
A total colectomy was performed to incorporate the transverse and simoid lesion with side to side stapled anastomosis of ileum to
rectum, the posterior uterine deposit was also resected. She made a routine recovery but this was complicated by ileus which required
placement of an NG tube for 5 days and a chest infection which required IV antibiotics. She was discharged 17 days after her surgery.
Macroscopically the specimen showed a 15 cm 9 cm 6 cm tumour which was adjacent to the serosal surface. The mucosa showed no
inﬂammation or ulceration (Fig. 2).
Microscopy showed a tumour with spindle shaped cells with eosinophilic, pigment free cytoplasm and elongated nuclei showing a mild
degree of pleomorphism. The initial impression was of a CD117 negative GIST. An expert external opinion to include DOG1 staining was
requested from the regional histopathology centre. The referral centre reported a well circumscribed tumour in the mesenteric/pericolic
fatty tissue with invasion into the muscularis propria. The tumour consisted of spindled to stellate cells in an alternating ﬁbrous andmyxoid
matrix. They were negative for DOG1 antibodies, but were strongly positive for MUC4 and EMA. Fluorescence in-situ hybridisation (FISH)ell).
by Elsevier Ltd on behalf of The Royal College of Pathologists. This is an open access article under the CC BY-NC-ND
d/3.0/).
Fig. 1. Transverse and coronal CT images showing the soft tissue mass.
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ﬁbromyxoid sarcoma (LGFS) rather than GIST as originally postulated.
The lesion in the uterus was a small benign leiomyoma and the sigmoid lesionwas benign tissue and notmicroscopically signiﬁcant (Figs.
3 and 4).
Supra-regional sarcoma MDT discussion did recommend adjuvant therapy and standard radiological/surgical follow up.2. Discussion
The immunohistochemistry stains performed on this sample were the key to the correct diagnosis. CD117 and DOG1 have been shown to
be the most sensitive stains for the diagnosis of gastrointestinal stromal tumours [1] both of which were negative in this case. MUC4 is
positive in several different tumours including pancreatic and oesophageal adenocarcinomas but is extremely sensitive and speciﬁc for
ﬁbromyxoid sarcoma where it is suspected [2]. FISH studies are used to detect the presence or absence of speciﬁc DNA sequences on
chromosomes. FUS (fused in sarcoma) gene rearrangement is highly speciﬁc for ﬁbromyxoid sarcoma [3].
Low grade ﬁbromyxoid sarcoma is in itself a rare tumour which most frequently presents in the trunk and deep tissues of the lower
extremities. It is a slowgrowing tumour, growing between 1 and 18 cm per year [4]. There is a high rate of recurrence (64%) and a high rate of
metastasis (45%), often very late (median 5 years) [5]. Death from the disease is common, occurring in 42% of cases [5]. LGFS appears to be
extremely uncommon in the GI tract. There have been 6 cases reported in the small bowel mesentery in the past but there appears to be only
one previous case of colonic ﬁbromyxoid sarcoma reported [6]. Had the DOG1 stain been available at this hospital, it is possible that thisFig. 2. Macroscopic image of the mass within the mesentery with adjacent colon.
Fig. 3. 16 power image showing spindled nature of the tumour cells.
Fig. 4. 100 power image showing surrounding myxoid change.
I.S. Farrell et al. / Pathogenesis 1 (2014) 1e3 3tumour may have been misdiagnosed as a GIST because it would not have gone on to have the MUC4 and FISH studies which were strongly
positive for a diagnosis of LGFS.
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